- Home
- JAZZ vs VNOM Comparison
JAZZ vs VNOM Comparison
Compare JAZZ & VNOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- VNOM
- Stock Information
- Founded
- JAZZ 2003
- VNOM 2013
- Country
- JAZZ Ireland
- VNOM United States
- Employees
- JAZZ N/A
- VNOM N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- VNOM Oil & Gas Production
- Sector
- JAZZ Health Care
- VNOM Energy
- Exchange
- JAZZ Nasdaq
- VNOM Nasdaq
- Market Cap
- JAZZ 6.5B
- VNOM 5.7B
- IPO Year
- JAZZ 2007
- VNOM 2014
- Fundamental
- Price
- JAZZ $122.38
- VNOM $50.90
- Analyst Decision
- JAZZ Buy
- VNOM Strong Buy
- Analyst Count
- JAZZ 14
- VNOM 8
- Target Price
- JAZZ $173.57
- VNOM $51.25
- AVG Volume (30 Days)
- JAZZ 613.8K
- VNOM 795.2K
- Earning Date
- JAZZ 11-06-2024
- VNOM 11-04-2024
- Dividend Yield
- JAZZ N/A
- VNOM 1.85%
- EPS Growth
- JAZZ 458.10
- VNOM 2.17
- EPS
- JAZZ 7.04
- VNOM 2.32
- Revenue
- JAZZ $3,992,712,000.00
- VNOM $794,412,000.00
- Revenue This Year
- JAZZ $7.43
- VNOM $10.29
- Revenue Next Year
- JAZZ $6.39
- VNOM $8.65
- P/E Ratio
- JAZZ $17.64
- VNOM $22.11
- Revenue Growth
- JAZZ 5.23
- VNOM 0.51
- 52 Week Low
- JAZZ $99.06
- VNOM $28.55
- 52 Week High
- JAZZ $134.17
- VNOM $56.08
- Technical
- Relative Strength Index (RSI)
- JAZZ 59.35
- VNOM 50.63
- Support Level
- JAZZ $108.74
- VNOM $52.11
- Resistance Level
- JAZZ $128.99
- VNOM $56.08
- Average True Range (ATR)
- JAZZ 2.93
- VNOM 1.28
- MACD
- JAZZ 1.13
- VNOM -0.35
- Stochastic Oscillator
- JAZZ 62.86
- VNOM 22.08
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About VNOM Viper Energy Inc.
Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties primarily in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.